These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8187662)

  • 1. Pharmacokinetics of albendazole in children with hydatid disease.
    Okelo GB; Hagos B; Ng'ang'a JN; Ogeto JO
    East Afr Med J; 1993 Oct; 70(10):643-5. PubMed ID: 8187662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2003 Jul; 24(5):199-204. PubMed ID: 12784319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma disposition and faecal excretion of oxfendazole, fenbendazole and albendazole following oral administration to donkeys.
    Gokbulut C; Akar F; McKellar QA
    Vet J; 2006 Jul; 172(1):166-72. PubMed ID: 16772142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of four benzimidazoles administered intragastrically to mice infected with secondary cysts of Echinococcus granulosus].
    Xiao SH; Wang MJ; You JQ; Jiao PY; Yang B; Chai JJ
    Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):430-4. PubMed ID: 1819898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dose increase or cimetidine co-administration on albendazole bioavailability.
    Schipper HG; Koopmans RP; Nagy J; Butter JJ; Kager PA; Van Boxtel CJ
    Am J Trop Med Hyg; 2000; 63(5-6):270-3. PubMed ID: 11421376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gender in the disposition of albendazole metabolites in humans.
    Mirfazaelian A; Dadashzadeh S; Rouini MR
    Eur J Clin Pharmacol; 2002 Sep; 58(6):403-8. PubMed ID: 12242599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipidic matrix of albendazole: an alternative for systemic infections.
    Savio E; Domínguez L; Malanga A; Quevedo D; Saldaña J; Camarote C; Ochoa A; Fagiolino P
    Boll Chim Farm; 1998 Oct; 137(9):345-9. PubMed ID: 9859596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis.
    Pengsaa K; Na-Bangchang K; Limkittikul K; Kabkaew K; Lapphra K; Sirivichayakul C; Wisetsing P; Pojjaroen-Anant C; Chanthavanich P; Subchareon A
    Ann Trop Med Parasitol; 2004 Jun; 98(4):349-57. PubMed ID: 15228716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and gender in the pharmacokinetics of albendazole and albendazole sulphoxide enantiomers in goats.
    Capece BP; Afonso SM; Lazáro R; Harun M; Godoy C; Castells G; Cristòfol C
    Res Vet Sci; 2009 Jun; 86(3):498-502. PubMed ID: 18805559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis.
    Jung H; Hurtado M; Sanchez M; Medina MT; Sotelo J
    J Clin Pharmacol; 1992 Jan; 32(1):28-31. PubMed ID: 1740534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose dependent pharmacokinetics of albendazole in human.
    Mirfazaelian A; Rouini MR; Dadashzadeh S
    Biopharm Drug Dispos; 2002 Dec; 23(9):379-83. PubMed ID: 12469331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of albendazole sulfoxide enantiomers administered in racemic form and separately in rats.
    Capece BP; Castells G; Godoy C; Arboix M; Cristòfol C
    Vet J; 2008 Aug; 177(2):297-9. PubMed ID: 17566773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of albendazole in New Zealand white rabbits: oral versus intraperitoneal administration.
    Cai ZY; Galettis P; Lu Y; Morris DL; Pourgholami MH
    Anticancer Res; 2007; 27(1A):417-22. PubMed ID: 17352262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of albendazole sulphoxide into hydatid cysts.
    Morris DL; Chinnery JB; Georgiou G; Stamatakis G; Golematis B
    Gut; 1987 Jan; 28(1):75-80. PubMed ID: 3817589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of albendazole in patients with neurocysticercosis.
    Castro N; Márquez-Caraveo C; Brundage RC; González-Esquivel D; Suárez AM; Góngora F; Jara A; Urizar J; Lanao JM; Jung H
    Int J Clin Pharmacol Ther; 2009 Nov; 47(11):679-85. PubMed ID: 19840532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic effect of albendazole in pediatric patients with hepatic hydatid disease.
    Oztas S; Salman AB; Tatar A; Yigiter M; Yazgi H; Ertek M; Yesilyurt A; Ocak Z; Kursad H
    Int J Infect Dis; 2007 Sep; 11(5):446-9. PubMed ID: 17331781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative plasma disposition of fenbendazole, oxfendazole and albendazole in dogs.
    Gokbulut C; Bilgili A; Hanedan B; McKellar QA
    Vet Parasitol; 2007 Sep; 148(3-4):279-87. PubMed ID: 17673370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite concentrations in plasma following treatment of cattle with five anthelmintics.
    Prichard RK; Hennessy DR; Steel JW; Lacey E
    Res Vet Sci; 1985 Sep; 39(2):173-8. PubMed ID: 4070784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of clotrimazole on microsomal metabolism and pharmacokinetics of albendazole.
    Merino G; Molina AJ; García JL; Pulido MM; Prieto JG; Alvarez AI
    J Pharm Pharmacol; 2003 Jun; 55(6):757-64. PubMed ID: 12841935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albendazole sulphoxide concentrations in plasma of endemic normals from a lymphatic filariasis endemic region using liquid chromatography.
    Sarin R; Dash AP; Dua VK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jan; 799(2):233-8. PubMed ID: 14670741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.